Consult with your healthcare provider or registered dietitian for personalized advice tailored to your specific condition
In August 2025, Eli Lilly (US) announced a collaboration with a leading technology firm to integrate artificial intelligence into its drug development processes
A study published in the New England Journal of Medicine (NEJM) in 2021 found that Wegovy led to a 15% reduction in body weight, on average
Some patients may qualify for insurance coverage depending on their insurance plan, diagnosis, pharmacy benefits, and eligibility requirements
This intelligence allows PlexusDx clinicians to recommend complementary lifestyle interventions, dietary adjustments, and potential medication combinations tailored to your biology
Wegovy, based on semaglutide, is already one of the most influential GLP-1 drugs globally, supported by strong clinical evidence and widespread brand recognition